global pharyngitis market.
To gain more valuable insights, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=361
The latest study by Fact.MR expects the global market for pharyngitis to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Pharyngitis is the most common manifestation of infection. Antibiotics are given in case of a sore throat, however, they provide very modest benefit. It is still unclear which antibiotic is the best for the treatment of a sore throat. Hence, various research and trials are being conducted to find most effective antibiotic.
Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.
Report Customization:https://www.factmr.com/connectus/sample?flag=RC&rep_id=361
Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.
Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.
Report Summary: https://www.factmr.com/report/361/pharyngitis-market
The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.
About Us
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.